Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4105864 Target Snapshot

Sigma intracellular receptor 2 · SINGLE PROTEIN · Rattus norvegicus

915Compounds
100Assays
10Approved Drugs
957.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q5U3Y7. Use UniProt Q5U3Y7 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q5U3Y7 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Sigma intracellular receptor 2 as ChEMBL target CHEMBL4105864, mapped to UniProt Q5U3Y7. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Sigma intracellular receptor 2
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-14
ChEMBL target ID
CHEMBL4105864
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q5U3Y7
Sigma intracellular receptor 2
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Sigma intracellular receptor 2 is the right protein anchor across sources, using UniProt Q5U3Y7 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelSigma intracellular receptor 2
UniProt AccessionQ5U3Y7
Component TypeProtein
Sequence Length176 aa

Sigma intracellular receptor 2

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Sigma intracellular receptor 2, mapped to UniProt Q5U3Y7. Sequence length is 176 aa.

Mapped IDQ5U3Y7
Review nameSigma intracellular receptor 2
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

10
Approved
4
Phase II
Assay Mix

Activity Type Distribution

KI956.0
KD1.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL61479 9.92 Ki 0.12 Clinical
CHEMBL53325 9.47 Ki 0.34 Preclinical
CHEMBL4744466 9.42 Ki 0.38 Preclinical
CHEMBL5271751 9.37 Ki 0.43 Preclinical
CHEMBL4531345 9.18 Ki 0.66 Preclinical
CHEMBL4746910 8.88 Ki 1.33 Preclinical
CHEMBL4581662 8.82 Ki 1.5 Preclinical
CHEMBL4542088 8.74 Ki 1.81 Preclinical
CHEMBL4584941 8.69 Ki 2.05 Preclinical
CHEMBL4740593 8.68 Ki 2.1 Preclinical
Distribution

pChEMBL Value Distribution

26
5.0
71
5.5
132
6.0
152
6.5
240
7.0
132
7.5
62
8.0
15
8.5
6
9.0
3
9.5
pChEMBL
Approved Drugs

Approved Drugs

PITOLISANT
CHEMBL462605
Approved 2016
DOLUTEGRAVIR
CHEMBL1229211
Approved 2013
HALOPERIDOL
CHEMBL54
Approved 1967
Assay Landscape

Assay Landscape

100
Total Assays
731
Tested Compounds
2
Assay Types
Binding — 99 assays, 731 compounds
BAO Format Assays Compounds Avg pChEMBL
cell membrane format 75 537 6.9
cell-based format 10 91 7.3
tissue-based format 8 66 7.3
assay format 3 35 6.6
single protein format 3 2 5.5
ADME — 1 assays, 24 compounds
BAO Format Assays Compounds Avg pChEMBL
cell membrane format 1 24 6.6

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine